Clinical trial

Pharmaceutical Management in Targeted Radioligand Therapy

NCT07389512

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2026-01-09

PhaseN/A

Study timeline

Study start (actual)2026-01-09Date precision: day

Registry last updated2026-02-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Cancerunresolved

Thyroid Cancerunresolved

Metastatic Prostate Cancerunresolved

Neuroendocrine Tumor Carcinoidunresolved

Interventions

Sponsors & collaborators

Hospices Civils de Lyonlead sponsor

Mapped research locations

LilleFrance1 DijonFrance1 BronFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07389512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.